< Back to latest news & events

Event

Webinar: Attracting big pharma to the Microbiome field

June 2020

Event date: 8th July 2020

HGF Partners Craig Thomson and Dr Andrew Wells will be presenting a webinar on ‘Attracting Big Pharma to the Microbiome Field’ on 8th July.

Join ‘Attracting Big Pharma to the Microbiome Field’ webinar by Arrowhead Publishers on 8th July at 1PM (CDT), where the presenters will discuss:

  • the advantages and disadvantages of engaging with Big Pharma
  • what attracts Big Pharma and broadly at the options open in the microbiome field
  • “Drugs from bugs” (bio-active molecules derived from bacteria), “Bugs as drugs” (therapeutic bacteria and phage with combinations of such from single strain to FMT), “Bugs for drugs” (the use of bacteria as adjuvant technology for enhancing “conventional” therapeutics)
  • hints and tips for those preparing to pitch their technology to one of the Big Pharma

HGF Partner Craig Thomson will be chairing a discussion between HGF Partner Dr Andrew Wells and Executive Director and Head of Investigational Biology at Merck’s Exploratory Science Center (ESC), who both have direct experience of what Big Pharma look for in emerging technologies.

Attendees

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

WIPR Diversity Top 100 2025

HGF’s European Patent Attorney Alexandra Wood has been listed in World IP Review’s (WIPR) Diversity Top 100 2025 World IP Review’s Diversity in IP listings 2025 recognises and celebrates people …

Read article

INTA 2025 Annual Meeting Live

The HGF European team will be attending the INTA Annual Meeting Live, which will take place on 17th-21st May in San Diego, US. The conference will connect some of the …

Read article

HGF wins big at the Managing IP EMEA Awards Ceremony 2025

The Annual Managing IP Awards: EMEA Awards 2025 were announced last night, and HGF are proud to have won 7 awards. The Managing IP Awards are highly recognised and respected …

Read article

Plant Patent Infringement in the US Relies on Evidence of Asexual Reproduction

A recent case in the US District Court for the Northern District of Texas (Dallas Division) once again highlights how important the initial pleadings and evidence in patent infringement cases …

Read article

Exam Success at HGF!

HGF is pleased to announce that several of our attorneys have passed their UK Advanced Patent exams! In no specific order, we would like to say well done and a …

Read article

IP Ingredients: How food companies are using IP to stay ahead of the GLP-1 curve

The impact of GLP-1 on the food and beverage sector GLP-1 agonists, best-known under the brand names Ozempic® and Wegovy®, are medicines used to treat type 2 diabetes and obesity. …

Read article